Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gábor Simonyi

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Cardiorenal Medicine|September 26, 2014
Electrocardiological features in obesity: the benefits of body surface potential mappingGábor Simonyi
Orvosi Hetilap|October 15, 2013
[Advantages of ramipril/amlodipin fixed combination therapy. When should we use it?]Gábor Simonyi
Orvosi Hetilap|April 24, 2014
[Lipid-lowering therapy and patient adherence in the MULTI GAP 2013 trial]Gábor Simonyi
Orvosi Hetilap|May 2, 2012
[New possibility in the oral glucose lowering treatment of type 2 diabetes mellitus: sodium-glucose co-transporter-2 inhibitors]Gábor Simonyi
Orvosi Hetilap|October 22, 2013
[Statins and the risk of diabetes]Gábor Simonyi
Orvosi Hetilap|October 1, 2013
[Patient adherence in antihypertensive treatment]Gábor Simonyi
Cardiology and Therapy|April 3, 2021
Supplementary Therapeutic Possibilities to Alleviate Myocardial Damage Due to Microvascular Dysfunction in Coronavirus Disease 2019 (COVID-19)Mihály Medvegy, Gábor Simonyi
Orvosi Hetilap|March 8, 2016
[One year persistence of atorvastatin and amlodipine fixed dose combination versus atorvastatin therapy]Gábor Simonyi, Tamás Ferenci
Orvosi Hetilap|January 20, 2015
[Low persistence of simvastatin and ezetimibe fixed combination in the lipid lowering therapy]Gábor Simonyi, Tamás Ferenci
Orvosi Hetilap|April 12, 2016
[One year persistence of metformin monotherapy versus metformin/sitagliptin fixed dose combination]Gábor Simonyi, Tamás Ferenci
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Cardiorenal Medicine|September 26, 2014
Electrocardiological features in obesity: the benefits of body surface potential mappingGábor Simonyi
Orvosi Hetilap|October 15, 2013
[Advantages of ramipril/amlodipin fixed combination therapy. When should we use it?]Gábor Simonyi
Orvosi Hetilap|April 24, 2014
[Lipid-lowering therapy and patient adherence in the MULTI GAP 2013 trial]Gábor Simonyi
Orvosi Hetilap|May 2, 2012
[New possibility in the oral glucose lowering treatment of type 2 diabetes mellitus: sodium-glucose co-transporter-2 inhibitors]Gábor Simonyi
Orvosi Hetilap|October 22, 2013
[Statins and the risk of diabetes]Gábor Simonyi
Orvosi Hetilap|October 1, 2013
[Patient adherence in antihypertensive treatment]Gábor Simonyi
Cardiology and Therapy|April 3, 2021
Supplementary Therapeutic Possibilities to Alleviate Myocardial Damage Due to Microvascular Dysfunction in Coronavirus Disease 2019 (COVID-19)Mihály Medvegy, Gábor Simonyi
Orvosi Hetilap|March 8, 2016
[One year persistence of atorvastatin and amlodipine fixed dose combination versus atorvastatin therapy]Gábor Simonyi, Tamás Ferenci
Orvosi Hetilap|January 20, 2015
[Low persistence of simvastatin and ezetimibe fixed combination in the lipid lowering therapy]Gábor Simonyi, Tamás Ferenci
Orvosi Hetilap|April 12, 2016
[One year persistence of metformin monotherapy versus metformin/sitagliptin fixed dose combination]Gábor Simonyi, Tamás Ferenci
Pageof 4